Search results
Results From The WOW.Com Content Network
The falling share price has pushed the stock's dividend yield to nearly 6%. ... The good news is that declining sales should soon end, and Pfizer can start replenishing its top line with growth ...
The current yield at 3.80% still outperforms the industry, but it mandates further examination as the ex-dividend date is just around the corner. Pfizer's Inc. (NYSE:PFE) Dividend is Depending on ...
A high-yield dividend stock with long-term potential Pfizer's current 5.73% dividend yield stands well above the S&P 500 average of 1.35%. The company's payout ratio of 443% appears unsustainable ...
Pfizer (NYSE: PFE) ranks among healthcare's most reliable dividend payers, but recent struggles have pushed its stock down 13.8% this year. That decline has lifted the yield to an enticing 6.77% ...
The past couple of years have been terrific for stocks, with the benchmark S&P 500 index up a whopping 57.1% since the end of 2022. The average stock in the S&P 500 index offers a yield of just 1. ...
Two good examples of stocks that pay more than 6% and can still be ideal long-term options for retirees are Pfizer (NYSE: PFE) and Verizon Communications (NYSE: VZ).
One stock yields 6% today. Another has grown its dividend by 460% over the past decade. Both are blue chip bargains to buy right now.
Notably, the stock's fantastic dividend is on solid ground. AbbVie currently yields 3.7%, and its dividend payout ratio is just 56% of its estimated 2024 earnings. So, the failure of emraclidine ...